Targeting breathlessness in heart failure
Perhaps we should look at a short‐acting opiates, taken akin to a nitrate spray by an angina patient, to enable a physical activity to be competed more easily such as climbing stairs or sexual intercourse, rather than always assuming all drugs need to be present for 24 hours. In this regard, a much...
Saved in:
Published in | ESC Heart Failure Vol. 6; no. 6; pp. 1103 - 1104 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
England
John Wiley & Sons, Inc
01.12.2019
John Wiley and Sons Inc Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Perhaps we should look at a short‐acting opiates, taken akin to a nitrate spray by an angina patient, to enable a physical activity to be competed more easily such as climbing stairs or sexual intercourse, rather than always assuming all drugs need to be present for 24 hours. In this regard, a much earlier trial showed significant efficacy of the mild opiate dihydrocodeine in reducing the sensation of dyspnoea during a progressive exercise test and being associated with a reduction in ventilatory drive, and leading to a significant increase in exercise tolerance, perhaps because it was given specifically timed to the performance of a bout of exercise. Another possibility is that some of the patients have central sleep apnoea where the pathophysiological mechanisms of nocturnal dyspnoea are partly related to chemoreflex hypersensitivity and periodic episodes of hyperventilation. |
---|---|
Bibliography: | SourceType-Other Sources-1 content type line 63 ObjectType-Editorial-2 ObjectType-Commentary-1 |
ISSN: | 2055-5822 2055-5822 |
DOI: | 10.1002/ehf2.12556 |